LANSING,
Mich., April 30, 2024 /PRNewswire/ --
Neogen® Corporation (NASDAQ: NEOG), a worldwide leader
in innovative solutions that help the food and beverage industries
ensure safety and quality in their products, announced today the
launch of the new Neogen Molecular Detection Assay 2 –
Salmonella Enteritidis/Salmonella Typhimurium
(MDA2SEST).
The product joins several other next-generation assays,
including Salmonella, E. coli O157 (including H7),
Listeria and Listeria monocytogenes,
Campylobacter, STEC gene screen (stx and eae),
and Cronobacter, as part of the Neogen Molecular Detection
System pathogen testing platform.
"We are pleased to bring this advanced technology to our
customers, helping them to enhance their food safety program and
address a challenging need in the poultry industry," said
John Adent, Neogen's President and
CEO. "This isothermal molecular assay overcomes certain limitations
of existing solutions, such as traditional serology and PCR-based
methods, with improved accuracy, reduced time to results, and a
streamlined workflow that provides increased productivity and
unparalleled ease of use."
The Neogen MDA2SEST kit is used with the Neogen Molecular
Detection System for rapid and specific detection of two
Salmonella serotypes, Salmonella enterica
subsp. enterica serotype Enteritidis (SE) and
Salmonella enterica subsp. enterica serotype
Typhimurium (including monophasic variant 1,4,[5],12:i:-) (ST), in
enriched poultry samples. Salmonella Enteritidis and
Salmonella Typhimurium are two serotypes that are pathogenic
to humans and have been implicated in Salmonella outbreaks.
By enabling the detection of specific serotypes such as S.
Enteritidis and S. Typhimurium, the MDA2SEST assay is an
important tool that can help reduce foodborne illness.
The Neogen MDA2SEST was granted approval by the AOAC®
Research Institute Performance Tested MethodsSM (PTM)
Program and assigned PTM Certification No. 122302. The PTM Program
provides independent third-party review and certification for
proprietary test method performance.
The award-winning Neogen Molecular Detection System platform is
used by food processors, universities, governments, and contract
testing laboratories in more than 40 countries. It is powered by a
combination of advanced technologies—isothermal DNA amplification
and bioluminescence detection—to provide a pathogen testing
solution that is fast, accurate, easy to use, and affordable. The
new assay for Salmonella Enteritidis and Salmonella
Typhimurium joins, and can be run concurrently with, molecular
tests already offered by Neogen for Salmonella, E.
coli O157 (including H7), Listeria and Listeria
monocytogenes, Campylobacter, STEC gene screen
(stx and eae), and Cronobacter.
Individuals interested in this new technology may contact their
local Neogen Food Safety representative or visit
https://www.neogen.com/molecular-detection-system to learn
more.
About Neogen
Neogen Corporation is committed to fueling a brighter future for
global food security through the advancement of human and animal
well-being. Harnessing the power of science and technology, Neogen
has developed comprehensive solutions spanning the Food Safety,
Livestock, and Pet Health & Wellness markets. A world leader in
these fields, Neogen has a presence in over 140 countries with a
dedicated network of scientists and technical experts focused on
delivering optimized products and technology for its customers.
Contact
Jean-Yves Mazzitelli | Global
Product Owner, Food Safety
JMazzitelli@Neogen.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/neogen-launches-new-molecular-method-for-detection-of-two-salmonella-serotypes-302131018.html
SOURCE Neogen Corporation